Sabinsa, the globally renowned research-oriented supplier known for its sustainable and innovative nutraceutical and cosmeceutical ingredients, will highlight LactoSpore^™ Weizmannia coagulans at the Expanding the Lineup: Next Probiotics and Supplement Spring Symposium hosted by the Korean Society for Lactic Acid Bacteria and Probiotics in Seoul, Korea on May 24, 2024.

Read more ...

Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, will be exhibiting at the International Food Ingredients & Additives (IFIA) Expo from May 22–24, 2024, at the Tokyo Big Sight Exhibition Center. The expo primarily focuses on functional foods, dietary supplements, and natural ingredient categories, and is a significant platform for food ingredient manufacturers.

Read more ...

Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, will showcase the company’s portfolio of innovative ingredients at Vitafoods Europe 2024 from 14^th to 16^th May, at the Palexpo SA International Exhibition Center in Geneva, Switzerland. As the official curcumin sponsor of the event, Sabinsa will highlight its revolutionary product, C3 Reduct^® - the only EFSA-approved curcuminoid product in the European market.

Read more ...

Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, will introduce a new product in booth # 1418 at the New York Society of Cosmetic Chemists (NYSCC) Suppliers’ Day at the Jacob Javits Center in New York May 1 – 2, 2024. Dr. Anurag Pande, Sabinsa’s VP of Scientific Affairs, will give a presentation designed to guide those brands seeking to add natural, sustainable ingredients to their formulas.

Read more ...

Sabinsa, the multi-national health science company founded by the late Dr. Muhammed Majeed 36 years ago, announces Dr. Anju Majeed as Sami-Sabinsa Group Executive Chairperson, assuming the role her father held until his death on March 13, 2024. The company also announced Shaheen Majeed as Global Managing Director & CEO.

Read more ...

Sami-Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 36 years ago, will be highlighting new clinical studies on Shagandha™ (Ashwagandha root extract 2.5% USP grade) for stress and anxiety in booth # 4253 at Expo West in Anaheim, CA March 13 – 16, 2024.

Read more ...

Sabinsa, the multi-national health science company founded 35 years ago by Dr. Muhammed Majeed, announces that Curcumin C³ Reduct^® has been approved by the National Health Surveillance Agency in Brazil for inclusion on ANVISA’s IN28 list. This approval allows introduction and commercialization of C³ Reduct^®, most active metabolite of curcumin, in food and supplements in Brazil. Approval is based on a dossier submitted to ANVISA detailing safety and efficacy of a product. C³ Reduct^® is the only Tetrahydrocurcuminoids approved in this market. C³ Reduct^® was given approval at dosage of 120mg/day.

Read more ...

Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, will begin the new year by relocating the Sabinsa Nanjing Biotechnology Company Limited corporate office to a new location in Nanjing, China. In addition to office space, the company will have a sizeable warehouse, repacking, QC, and meeting rooms on the premises. .

Read more ...

Sami-Sabinsa, the multi-national health science company founded by Dr. Muhammed Majeed 35 years ago, announces the most recent clinical study on its branded 2.5% USP grade Ashwagandha root ingredient: Shagandha^™. The study, published in the journal Medicine, suggested that Shagandha^™ can effectively reduce stress and anxiety by decreasing cortisol and increasing serotonin in healthy individuals with mild to moderate stress-related symptoms, compared to placebo.

Read more ...